Algernon Pharmaceuticals Inc (AGNPF)

[medchem]

My 2 cents:

Look back through the news releases and you will be able to see that they have been enrolling patients VERY fast across their sites. They have been recruiting 25% of patients every 3 weeks approximately. They hit 75% nearly that long ago. We will have news on 100% this week.

If the trial data is positive, this will be ground breaking and the share price will explode as it moves into phase 3.

We already knows it is safe because the safety data monitoring board approved it a while ago. That was the biggest hurdle and we are past that.